In Silico Prioritisation of MicroRNA-associated Common Variants in Multiple Sclerosis

Overview

Journal Hum Genomics

Publisher Biomed Central

Specialty Genetics

Date 2023 Mar 29

PMID 36991503

Authors

Ifeolutembi A Fashina

Claire E McCoy

Simon J Furney

Affiliations

Soon will be listed here.

Abstract

Background: Genome-wide association studies (GWAS) have highlighted over 200 autosomal variants associated with multiple sclerosis (MS). However, variants in non-coding regions such as those encoding microRNAs have not been explored thoroughly, despite strong evidence of microRNA dysregulation in MS patients and model organisms. This study explores the effect of microRNA-associated variants in MS, through the largest publicly available GWAS, which involved 47,429 MS cases and 68,374 controls.

Methods: We identified SNPs within the coordinates of microRNAs, ± 5-kb microRNA flanking regions and predicted 3'UTR target-binding sites using miRBase v22, TargetScan 7.0 RNA22 v2.0 and dbSNP v151. We established the subset of microRNA-associated SNPs which were tested in the summary statistics of the largest MS GWAS by intersecting these datasets. Next, we prioritised those microRNA-associated SNPs which are among known MS susceptibility SNPs, are in strong linkage disequilibrium with the former or meet a microRNA-specific Bonferroni-corrected threshold. Finally, we predicted the effects of those prioritised SNPs on their microRNAs and 3'UTR target-binding sites using TargetScan v7.0, miRVaS and ADmiRE.

Results: We have identified 30 candidate microRNA-associated variants which meet at least one of our prioritisation criteria. Among these, we highlighted one microRNA variant rs1414273 (MIR548AC) and four 3'UTR microRNA-binding site variants within SLC2A4RG (rs6742), CD27 (rs1059501), MMEL1 (rs881640) and BCL2L13 (rs2587100). We determined changes to the predicted microRNA stability and binding site recognition of these microRNA and target sites.

Conclusions: We have systematically examined the functional, structural and regulatory effects of candidate MS variants among microRNAs and 3'UTR targets. This analysis allowed us to identify candidate microRNA-associated MS SNPs and highlights the value of prioritising non-coding RNA variation in GWAS. These candidate SNPs could influence microRNA regulation in MS patients. Our study is the first thorough investigation of both microRNA and 3'UTR target-binding site variation in multiple sclerosis using GWAS summary statistics.

References

Kozomara A, Birgaoanu M, Griffiths-Jones S . miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018; 47(D1):D155-D162. PMC: 6323917. DOI: 10.1093/nar/gky1141. View

. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell. 2018; 175(6):1679-1687.e7. PMC: 6269166. DOI: 10.1016/j.cell.2018.09.049. View

Fang L, Sorensen P, Sahana G, Panitz F, Su G, Zhang S . MicroRNA-guided prioritization of genome-wide association signals reveals the importance of microRNA-target gene networks for complex traits in cattle. Sci Rep. 2018; 8(1):9345. PMC: 6008395. DOI: 10.1038/s41598-018-27729-y. View

Gong J, Tong Y, Zhang H, Wang K, Hu T, Shan G . Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2011; 33(1):254-63. DOI: 10.1002/humu.21641. View

Afrasiabi A, Fewings N, Schibeci S, Keane J, Booth D, Parnell G . The Interaction of Human and miRNAs with Multiple Sclerosis Risk Loci. Int J Mol Sci. 2021; 22(6). PMC: 8000127. DOI: 10.3390/ijms22062927. View

Miranda K, Huynh T, Tay Y, Ang Y, Tam W, Thomson A . A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006; 126(6):1203-17. DOI: 10.1016/j.cell.2006.07.031. View

Chen L, Ge B, Casale F, Vasquez L, Kwan T, Garrido-Martin D . Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells. Cell. 2016; 167(5):1398-1414.e24. PMC: 5119954. DOI: 10.1016/j.cell.2016.10.026. View

Elton T, Yalowich J . Experimental procedures to identify and validate specific mRNA targets of miRNAs. EXCLI J. 2016; 14:758-90. PMC: 4817421. DOI: 10.17179/excli2015-319. View

Sakaue S, Hirata J, Maeda Y, Kawakami E, Nii T, Kishikawa T . Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity. Nucleic Acids Res. 2018; 46(22):11898-11909. PMC: 6294505. DOI: 10.1093/nar/gky1066. View

10.

Forrest A, Kawaji H, Rehli M, Baillie J, de Hoon M, Haberle V . A promoter-level mammalian expression atlas. Nature. 2014; 507(7493):462-70. PMC: 4529748. DOI: 10.1038/nature13182. View

11.

Oksenberg J, Baranzini S, Sawcer S, Hauser S . The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008; 9(7):516-26. DOI: 10.1038/nrg2395. View

12.

Schmiedel B, Singh D, Madrigal A, Valdovino-Gonzalez A, White B, Zapardiel-Gonzalo J . Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression. Cell. 2018; 175(6):1701-1715.e16. PMC: 6289654. DOI: 10.1016/j.cell.2018.10.022. View

13.

Kehl T, Backes C, Kern F, Fehlmann T, Ludwig N, Meese E . About miRNAs, miRNA seeds, target genes and target pathways. Oncotarget. 2018; 8(63):107167-107175. PMC: 5739805. DOI: 10.18632/oncotarget.22363. View

14.

Lorenz R, Bernhart S, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler P . ViennaRNA Package 2.0. Algorithms Mol Biol. 2011; 6:26. PMC: 3319429. DOI: 10.1186/1748-7188-6-26. View

15.

Lang F, Singh Y, Salker M, Ma K, Pandyra A, Lang P . Glucose transport in lymphocytes. Pflugers Arch. 2020; 472(9):1401-1406. DOI: 10.1007/s00424-020-02416-y. View

16.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

17.

Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielski E . dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2000; 29(1):308-11. PMC: 29783. DOI: 10.1093/nar/29.1.308. View

18.

Quach H, Rotival M, Pothlichet J, Loh Y, Dannemann M, Zidane N . Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations. Cell. 2016; 167(3):643-656.e17. PMC: 5075285. DOI: 10.1016/j.cell.2016.09.024. View

19.

Juzwik C, Drake S, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A . microRNA dysregulation in neurodegenerative diseases: A systematic review. Prog Neurobiol. 2019; 182:101664. DOI: 10.1016/j.pneurobio.2019.101664. View

20.

Bjornevik K, Cortese M, Healy B, Kuhle J, Mina M, Leng Y . Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022; 375(6578):296-301. DOI: 10.1126/science.abj8222. View